Literature DB >> 34799404

Disruption of β-Catenin-Dependent Wnt Signaling in Colon Cancer Cells Remodels the Microenvironment to Promote Tumor Invasion.

George T Chen1, Delia F Tifrea2, Rabi Murad3, Amber N Habowski1, Yung Lyou1, Madeleine R Duong1, Linzi Hosohama1, Ali Mortazavi3, Robert A Edwards2, Marian L Waterman1.   

Abstract

The recent classification of colon cancer into molecular subtypes revealed that patients with the poorest prognosis harbor tumors with the lowest levels of Wnt signaling. This is contrary to the general understanding that overactive Wnt signaling promotes tumor progression from early initiation stages through to the later stages including invasion and metastasis. Here, we directly test this assumption by reducing the activity of ß-catenin-dependent Wnt signaling in colon cancer cell lines at either an upstream or downstream step in the pathway. We determine that Wnt-reduced cancer cells exhibit a more aggressive disease phenotype, including increased mobility in vitro and disruptive invasion into mucosa and smooth muscle in an orthotopic mouse model. RNA sequencing reveals that interference with Wnt signaling leads to an upregulation of gene programs that favor cell migration and invasion and a downregulation of inflammation signatures in the tumor microenvironment. We identify a set of upregulated genes common among the Wnt perturbations that are predictive of poor patient outcomes in early-invasive colon cancer. Our findings suggest that while targeting Wnt signaling may reduce tumor burden, an inadvertent side effect is the emergence of invasive cancer. IMPLICATIONS: Decreased Wnt signaling in colon tumors leads to a more aggressive disease phenotype due to an upregulation of gene programs favoring cell migration in the tumor and downregulation of inflammation programs in the tumor microenvironment; these impacts must be carefully considered in developing Wnt-targeting therapies. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34799404      PMCID: PMC8898281          DOI: 10.1158/1541-7786.MCR-21-0349

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   6.333


  62 in total

1.  Possible involvement of Wnt11 in colorectal cancer progression.

Authors:  Mitsuaki Nishioka; Koji Ueno; Shoichi Hazama; Toshiyuki Okada; Kouhei Sakai; Yutaka Suehiro; Naoko Okayama; Hiroshi Hirata; Masaaki Oka; Kohzoh Imai; Rajvir Dahiya; Yuji Hinoda
Journal:  Mol Carcinog       Date:  2011-12-07       Impact factor: 4.784

2.  Apoptosis and APC in colorectal tumorigenesis.

Authors:  P J Morin; B Vogelstein; K W Kinzler
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

3.  A uniform human Wnt expression library reveals a shared secretory pathway and unique signaling activities.

Authors:  Rani Najdi; Kyle Proffitt; Stephanie Sprowl; Simran Kaur; Jia Yu; Tracy M Covey; David M Virshup; Marian L Waterman
Journal:  Differentiation       Date:  2012-07-09       Impact factor: 3.880

4.  Identification of human myometrial target genes of the cAMP pathway: the role of cAMP-response element binding (CREB) and modulator (CREMalpha and CREMtau2alpha) proteins.

Authors:  Jarrod Bailey; Alison J Tyson-Capper; Kate Gilmore; Stephen C Robson; G Nicholas Europe-Finner
Journal:  J Mol Endocrinol       Date:  2005-02       Impact factor: 5.098

5.  Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer.

Authors:  Michal Sheffer; Manny D Bacolod; Or Zuk; Sarah F Giardina; Hanna Pincas; Francis Barany; Philip B Paty; William L Gerald; Daniel A Notterman; Eytan Domany
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-09       Impact factor: 11.205

6.  Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer.

Authors:  Kira T Pate; Chiara Stringari; Stephanie Sprowl-Tanio; Kehui Wang; Tara TeSlaa; Nate P Hoverter; Miriam M McQuade; Chad Garner; Michelle A Digman; Michael A Teitell; Robert A Edwards; Enrico Gratton; Marian L Waterman
Journal:  EMBO J       Date:  2014-05-13       Impact factor: 11.598

7.  Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer.

Authors:  J Joshua Smith; Natasha G Deane; Fei Wu; Nipun B Merchant; Bing Zhang; Aixiang Jiang; Pengcheng Lu; J Chad Johnson; Carl Schmidt; Christina E Bailey; Steven Eschrich; Christian Kis; Shawn Levy; M Kay Washington; Martin J Heslin; Robert J Coffey; Timothy J Yeatman; Yu Shyr; R Daniel Beauchamp
Journal:  Gastroenterology       Date:  2009-11-13       Impact factor: 22.682

8.  Xenome--a tool for classifying reads from xenograft samples.

Authors:  Thomas Conway; Jeremy Wazny; Andrew Bromage; Martin Tymms; Dhanya Sooraj; Elizabeth D Williams; Bryan Beresford-Smith
Journal:  Bioinformatics       Date:  2012-06-15       Impact factor: 6.937

9.  Trimmomatic: a flexible trimmer for Illumina sequence data.

Authors:  Anthony M Bolger; Marc Lohse; Bjoern Usadel
Journal:  Bioinformatics       Date:  2014-04-01       Impact factor: 6.937

10.  GENCODE reference annotation for the human and mouse genomes.

Authors:  Adam Frankish; Mark Diekhans; Anne-Maud Ferreira; Rory Johnson; Irwin Jungreis; Jane Loveland; Jonathan M Mudge; Cristina Sisu; James Wright; Joel Armstrong; If Barnes; Andrew Berry; Alexandra Bignell; Silvia Carbonell Sala; Jacqueline Chrast; Fiona Cunningham; Tomás Di Domenico; Sarah Donaldson; Ian T Fiddes; Carlos García Girón; Jose Manuel Gonzalez; Tiago Grego; Matthew Hardy; Thibaut Hourlier; Toby Hunt; Osagie G Izuogu; Julien Lagarde; Fergal J Martin; Laura Martínez; Shamika Mohanan; Paul Muir; Fabio C P Navarro; Anne Parker; Baikang Pei; Fernando Pozo; Magali Ruffier; Bianca M Schmitt; Eloise Stapleton; Marie-Marthe Suner; Irina Sycheva; Barbara Uszczynska-Ratajczak; Jinuri Xu; Andrew Yates; Daniel Zerbino; Yan Zhang; Bronwen Aken; Jyoti S Choudhary; Mark Gerstein; Roderic Guigó; Tim J P Hubbard; Manolis Kellis; Benedict Paten; Alexandre Reymond; Michael L Tress; Paul Flicek
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

View more
  2 in total

1.  Mechanistic Clues Provided by Concurrent Changes in the Expression of Genes Encoding the M1 Muscarinic Receptor, β-Catenin Signaling Proteins, and Downstream Targets in Adenocarcinomas of the Colon.

Authors:  Madeline Alizadeh; Alyssa Schledwitz; Kunrong Cheng; Jean-Pierre Raufman
Journal:  Front Physiol       Date:  2022-03-16       Impact factor: 4.566

2.  Transcriptome Analysis of the Anti-Proliferative Effects of Ginsenoside Rh3 on HCT116 Colorectal Cancer Cells.

Authors:  Siying Teng; Xi Lei; Xinmin Zhang; Dongming Shen; Qiuyi Liu; Yingjie Sun; Yi Wang; Zhongyi Cong
Journal:  Molecules       Date:  2022-08-06       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.